This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Will today's weaker job numbers have a lasting effect on stocks? That's the question Jim Cramer pondered on "Mad Money" Friday as he laid out his game plan for next week's trading.

Cramer said it's not an all-or-nothing game. Some sectors of the market do better in a low-growth, low-interest rate environment while others will do poorly. That makes Cramer cautious in some areas but not others.

One area where Cramer's not worried: biotech, as the JPMorgan Biotech Conference kicks off next week. Cramer said that historically the biotech stocks rise as this conference gets underway, a move investors don't want to miss. Cramer's "four horsemen" of biotech remain faves but he advised taking profits in Intercept Pharmaceuticals (ICPT) after that stock's monster run.

On Tuesday, Cramer said he'll be watching the earnings from JPMorgan Chase (JPM), a stock which Cramer owns for his charitable trust, Action Alerts PLUS, and Wells Fargo (WFC). He's bullish on both names.

Wednesday brings earnings from Cramer's favorite financial, Bank of America (BAC), another AAP holding, while Thursday brings even more financial earnings, this time from Citigroup (C), Goldman Sachs (GS) and Capital One (COF).

Also on Thursday, PPG (PPG), another Cramer fave, and UnitedHealth Group (UNH), a company Cramer declared as a winner in the new world of health care.

Ending the week, it's earnings from two more Action Alerts PLUS holdings, General Electric (GE) and Morgan Stanley (MS). Cramer said he's bullish on both these names, but is less certain what Schlumberger (SLB) will have to say on its conference call.

Stealth Technology

Investors worried that the markets could take a turn for the worse should stick with long-term themes that are working, Cramer told viewers. One such theme is a notion Cramer calls "stealth technology" -- companies outside of the tech world that are innovating to bring investors huge profits.

Stealth technology companies come in all sorts of industries, said Cramer, from apparel to consumer goods to restaurants. Every one is inventing new products and in some cases, whole new categories of products.

One such company is Colgate-Palmolive (CL), which has invented a new Optic White toothpaste, Palmolive detergents that de-stink your sponges and Science Diet pet foods. It's no wonder Colgate commandeered 69% of the Brazilian toothpaste market.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs